405520-25-4

Upstream product

• 405520-49-2 4-amino-4'-(trifluoromethyl)-3-biphenylcarbonitrile 

Downstream Products

• 1040405-77-3 N-[3,5-bis(trifluoromethyl)phenyl]-2-[3-(1H-tetrazol-5-yl)-4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]-hydrazine carboxamide 
• 1080029-16-8 N-[3-(1H-tetrazol-5-yl)-4'-trifluoromethyl-biphenyl-4-yl]-3,5-bis-trifluoromethyl-benzamide 
• 1080029-15-7 N-hydroxy-N'-[3-(1H-tetrazol-5-yl)-4'-trifluoromethyl-biphenyl-4-yl]-3,5-bis-trifluoromethyl-benzamidine 
• 1080029-13-5 N-amino-N'-[3-(1H-tetrazol-5-yl)-4'-trifluoromethyl-biphenyl-4-yl]-3,5-bis-trifluoromethyl-benzamidine 
• 1080029-14-6 5-(3,5-bis-trifluoromethyl-phenyl)-4-[3-(2H-tetrazol-5-yl)-4'-trifluoromethyl-biphenyl-4-yl]-2,4-dihydro-[1,2,4]triazol-3-one 

Relevant academic research and scientific papers

DIPHENYLUREA DERIVATIVES USEFUL AS POTASSIUM CHANNEL ACTIVATORS

The present invention relates to the medical use of a certain group of diphenyl urea derivatives as potassium channel blockers for treating cardiovascular diseases, an obstructive or inflammatory airway disease, urinary incontinence, psychosis, epilepsy o

DIPHENYLUREA DERIVATIVES AND THEIR USE AS CHLORIDE CHANNEL BLOCKERS

The present invention relates to novel diphenylurea derivatives useful as chloride channel blockers. In other aspects the invention relates to the use of these compounds in a method for therapy, and to pharmaceutical compositions comprising the compounds